409A Valuations for Seed-Stage Startups: What Founders Get Wrong

You raised your seed round.

You have cash in the bank, a growing team, and a new preferred-share price investors were willing to pay.

Now you want to issue stock options to the next wave of employees.

This is where a deceptively simple question shows up:

What should the exercise price be?

For private startups, answering that question often involves a 409A valuation. And while founders don't need to become valuation experts, they do need to understand what a 409A is doing—and the mistakes that can create unnecessary problems later.

Here are some of the biggest things seed-stage founders get wrong.

First: What Is a 409A Valuation?

A 409A valuation determines the fair market value (FMV) of a private company's common stock.

That matters because stock options generally need to be granted with an exercise price at least equal to the fair market value of the underlying common stock on the grant date to qualify for an exemption from Section 409A's deferred-compensation rules.

For a private company, there isn't a public market telling you what one share of common stock is worth.

So that value has to be determined using a reasonable valuation method.

For many venture-backed startups, an independent third-party 409A appraisal is the practical route because, when applicable requirements are satisfied, an independent appraisal can receive a presumption of reasonableness under the regulations.

Getting the report isn't the end of the job.

You have to use it correctly.

Mistake #1: Assuming Your 409A Should Match Your Fundraising Valuation

This is probably one of the biggest points of confusion.

Imagine your startup just raised a seed round at a $15 million post-money valuation.

It might seem logical to divide $15 million by the company's shares and use that number as the value of employee stock options.

That's not how it works.

Investors in a priced financing typically purchase preferred stock.

Employees generally receive options to purchase common stock.

Those securities can have very different economic rights.

Preferred stock may include liquidation preferences and other rights or protections that common shareholders don't receive.

So the price investors paid for preferred shares and the fair market value of common shares are related pieces of information—but they aren't automatically the same number.

That's one reason a financing round often becomes an important input into a new 409A valuation rather than simply becoming the exercise price.

Mistake #2: Treating a 409A as Good for Exactly 12 Months No Matter What

You'll often hear:

"A 409A is good for 12 months."

That's incomplete.

Under the valuation rules, a previously calculated value may no longer be reasonable if new information becomes available that materially affects the company's value. A valuation that's more than 12 months old also presents a problem.

For founders, the important concept is the material event.

Examples could include:

• Closing a new financing
• Receiving a significant acquisition offer
• Major changes in financial performance
• Winning or losing a major customer
• Issuing valuable intellectual property
• Other developments that materially change the company's value

If something significant happens six months after your valuation, you shouldn't automatically assume you have another six months before thinking about 409A again.

Ask whether the facts have materially changed.

Mistake #3: Waiting Until You're Ready to Issue Options

You hire someone.

You negotiate their compensation.

Their offer includes equity.

The board is ready to approve the grant.

Then someone asks:

"Do we have a current 409A?"

That's the wrong time to discover that your valuation is outdated.

409A should be part of the company's equity-management process, not an administrative scramble every time someone needs an option grant.

Before hiring ramps up, founders should understand:

• When the current valuation was completed
• What has changed since then
• Whether a new financing or other event affects it
• When additional grants are expected
• Who is responsible for monitoring the process

A little planning can prevent a lot of unnecessary cleanup.

Mistake #4: Thinking the Goal Is to Get the Lowest Number Possible

Employees naturally benefit from a lower exercise price because it reduces the amount they must pay to exercise their options.

That can tempt founders to think:

Lower 409A = better 409A.

Not necessarily.

The objective isn't to negotiate the valuation down as far as possible.

The objective is to establish a supportable fair market value using a reasonable valuation methodology.

A valuation should account for relevant information about the company, which may include assets, anticipated cash flows, comparable companies, recent arm's-length transactions and other facts affecting value.

You want a valuation you can reasonably stand behind—not simply the smallest number someone will put in a report.

Mistake #5: Forgetting That 409A Is Part of a Bigger Equity System

A perfect valuation doesn't fix a messy equity process.

Your company still needs accurate cap-table records.

Option grants still need to be properly approved.

Grant dates, exercise prices and share amounts need to match the underlying documentation.

Equity promises made during recruiting need to become actual grants through the company's proper process.

The valuation being used should still be appropriate when those grants are made.

This becomes increasingly important as the company grows.

At five employees, founders may be able to keep most of the equity picture in their heads.

At 25 employees, multiple financing rounds, advisors, former employees and hundreds of thousands—or millions—of options outstanding, that approach stops working.

A Better 409A Process for Seed-Stage Startups

The process doesn't need to be complicated.

When you're preparing to issue equity, ask:

1. Do we have a current valuation?

2. Has anything material happened since it was completed?

3. Are we using the correct FMV when grants are approved?

4. Are the board approvals, cap table and grant documents consistent?

5. Is someone responsible for monitoring when the next valuation may be needed?

Those five questions can prevent a surprising amount of confusion.

Treat Equity Like the Asset It Is

Founders spend enormous amounts of time negotiating fundraising terms and thinking about dilution.

But what happens between financing rounds matters too.

Equity is one of the primary tools startups use to recruit people they couldn't otherwise afford to hire. Managing it well means understanding not just how much you're giving away, but how those grants are valued, approved, documented and maintained.

A 409A valuation isn't simply another compliance document to file away.

It's part of building a company whose ownership records can withstand the scrutiny that comes with growth, fundraising, diligence and eventually—if things go well—an exit.

At ForgeUp, we help founders build the infrastructure behind growth, including the legal and operational foundations that become increasingly important as a company scales.

Because the best time to clean up your equity process isn't during diligence.

It's before anyone has a reason to question it.

This article is for general informational purposes only and does not constitute legal, tax, accounting, or valuation advice. Founders should consult qualified legal, tax and valuation professionals regarding their specific circumstances.

‍

‍